For Immediate Release: April 2, 2019
513-579-9911 x 12627
Medpace is Honored to Receive 5 CRO Leadership Awards
Life Science Leader recognized Medpace in five core categories for clinical research.
CINCINNATI, OH — (April 2, 2019) – Medpace (MEDP), a scientifically-driven, global full-service clinical research organization (CRO), has been recognized with five CRO Leadership Awards from Life Science Leader magazine. Now in its 8th year, Life Science Leader’s CRO Leadership Awards provides accurate and reliable customer feedback to assist in choosing a reputable partner for clinical research needs. For the 2019 CRO Leadership Awards, Life Science Leader magazine teamed up with Industry Standard Research (ISR) to determine the award recipients. 60 contract research organizations were assessed on 20+ performance metrics in ISR’s annual CRO Quality Benchmarking survey.
Medpace has won a 2019 CRO Leadership Award in the following categories:
- Capabilities (Overall, Small Pharma)
- Compatibility (Overall, Small Pharma)
- Expertise (Overall, Small Pharma)
- Quality (Overall, Small Pharma)
- Reliability (Overall, Small Pharma)
“Life Science Leader is proud to once again be working with ISR Reports to honor those CROs that have proven themselves to be the top performers in Compatibility, Capabilities, Expertise, Quality, Reliability, and Phase IV. The winners are selected by their pharma clients, who rate their CROs on 20+ different performance metrics. We believe the CROs receiving an award this year are truly at the top of their class and are deserving of this recognition. Being a top performer in any of these categories shows a level of expertise and commitment to clinical trials and serving the needs of biopharmaceutical companies and their patients.” Ed Miseta, Executive Editor, Life Science Leader.
Medpace will attend the CRO Leadership Awards Presentation on Monday, June 24, 2019 in San Diego hosted during this year’s DIA 2019 Global Annual Meeting.
“Clinical development is complex and scientifically-demanding – success requires expertise, experience, and a disciplined team collaborating in unison,” commented Jesse Geiger, Chief Operating Officer, Laboratory Operations and CFO. “Being recognized in five categories is a reflection of our employees and their dedication to our mission of accelerating clinical development. We’re honored to be recognized for their hard work in delivering in the areas of Capabilities, Compatibility, Expertise, Quality, and Reliability.”
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,900 people across 36 countries.